𝔖 Bobbio Scriptorium
✦   LIBER   ✦

All-transretinoic acid plus low doses of cytarabine for the treatment of “poor-risk” acute myeloid leukemias

✍ Scribed by A. Venditti; R. Stasi; M. Masi; G. Del Poeta; C. Cox; A. Franchi; D. Piccioni; A. Bruno; U. Coppetelli; M. Tribalto; G. Papa

Publisher
Springer
Year
1993
Tongue
English
Weight
163 KB
Volume
66
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine, cytarabine, and G-CSF (FLAG
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
✍ Montillo, Marco; Mirto, Salvatore; Petti, Maria Concetta; Latagliata, Roberto; M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Thirty-eight patients with primary resistant or relapsing acute myeloid leukemia (AML) were treated with fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG). Median age was 41 (range 11-70). Sixteen patients had AML that was primary resistant to induction treatment, while 22 wer